Current Report
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Date
of report (Date of earliest event reported): September 27,
2007
|
|
|
|
JPMORGAN
CHASE & CO.
|
|
(Exact
Name of Registrant
as
Specified in Charter)
|
|
|
|
|
DELAWARE
|
|
|
(State
or Other Jurisdiction of Incorporation)
|
|
|
|
001-05805
|
|
13-2624428
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
|
|
270
Park Avenue,
New
York, NY
|
|
10017
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
|
|
|
|
|
|
Registrant’s
telephone number, including area code:
(212)
270-6000
|
|
|
|
|
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
The
following Exhibit is incorporated by reference into the Registration Statement
on Form S-3ASR (333-130051) of JPMorgan Chase & Co. (the “Registrant”) as an
exhibit thereto and is filed as part of this Current Report.
|
8.1
|
Tax
Opinion of Davis Polk & Wardwell relating to Buffered Return Enhanced
Notes Linked to the S&P 500
®
Index due
October 23, 2008
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
JPMORGAN
CHASE & CO.
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
|
|
Name:
|
|
|
|
|
Title:
|
|
Dated: October
1, 2007
EXHIBIT
INDEX
|
Exhibit
Number
|
|
Description
|
|
8.1
|
|
Tax
Opinion of Davis Polk & Wardwell relating to Buffered Return Enhanced
Notes Linked to the S&P 500
®
Index due
October 23, 2008
|
4
Exhibit
8.1
DAVIS
POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW
YORK,
NEW YORK 10017
JPMorgan
Chase & Co.
270
Park
Avenue
New
York,
New York 10017
Ladies
and
Gentlemen:
We
have acted as special tax counsel to
JPMorgan Chase & Co., a corporation incorporated under the laws of Delaware
(the “Company”), in connection with the preparation and filing of pricing
supplement no. 717 dated September 27, 2007 relatin
g to
Buffered Return
Enhanced
Notes Linked to the S&P 500
®
Index due October
23, 2008
(the “Pricing
Supplement”) to product supplement no. 18-I dated March 16, 2006 relating to
Return Enhanced
Notes
Linked to the
S&P 500
®
Index (the “Product
Supplement”) to a prospectus supplement dated December 1, 2005 (the “Prospectus
Supplement”) for the Company’s Global Medium-Term Notes, Series E, Global
Warrants, Series E and Global Units, Series E, relating to a prospectus
dated
December 1, 2005 (the “Prospectus”) contained in the Company’s Registration
Statement on Form S-3ASR (Registration Statement No. 333-130051) (the
“Registration Statement”). This opinion is being furnished in
accordance with the requirements of Section 601(b)(8) of Regulation
S-K of the
Securities Act of 1933, as amended (the “Act”).
In
our opinion, the discussions under
the heading “United States Federal Taxation” in the Prospectus Supplement, under
the heading “Certain U.S. Federal Income Tax Consequences” in the Product
Supplement and under the heading “Selected Purchase Considerations –
Capital Gains Tax Treatment” in the
Pricing Supplement
, subject to the conditions and limitations described
therein, set forth the material U.S. federal income tax considerations
applicable generally to holders of the securities offered pursuant
to the
Pricing Supplement as a result of the ownership and disposition of
such
securities.
We
hereby consent to the filing of this
opinion as an exhibit to the Registration Statement and to the references
to us
under the heading “United States Federal Taxation” in the Prospectus Supplement,
under the heading “Certain U.S. Federal Income Tax Consequences” in the Product
Supplement and under the heading “Selected Purchase Considerations –
Capital Gains Tax Treatment” in the
Pricing Supplement
. By such consent we do not concede that we
are an “expert” for the purposes of the Act.
|
|
Very
truly yours,
|
|
|
|
|
|
/s/
Davis Polk & Wardwell
|